Ulim said:
entheogenic-gnosis said:
Ulim said:
Well its not really the tolerance i think but your technique of smoking.
A the best way to lower your dmt tolerance is with MAOI use. All those 5-30mg ego deaths are almost always in combination with harmalas.
You might wanna lock into the less technique reliant methods of administration like aya or electric vaporizers and gvg.
I'm not certain that unusual MAOI levels are the only contributing factor to being "hard headed" with DMT.
I feel your genetic expression of 5HT2C/2a receptors may also contribute...as well as many other factors.
-eg
Yeah that too.
dogga94 do you use any kind of antidepressant or ever used one? Because those will effectively block anything that tries to interact with 5-HT2A
5-HT1A receptors are intrinsically involved in the mechanism of action of most antidepressant drugs...
Some antidepressant compounds are mono amine oxidase inhibitors, which would be a concern as well.
And as was mentioned in the previous post by ulim there are 5HT2a antagonists used as antidepressants as well:
A few antidepressant drugs (nefazodone, trazodone, mirtazapine) are antagonists of certain receptors, such as 5-HT2A or α2-adrenoceptors, a property that may underlie their therapeutic properties.
The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects. They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic ...
www.ncbi.nlm.nih.gov
Here's my understanding of SSRI drugs:
The serotonin transporter or "SERT" is a monoamine transporter protein, a membrane protein that transports 5-hydroxy-tryptamine from the synaptic cleft into presynaptic neurons, SSRI compounds function by blocking the serotonin transporter (SERT), preventing the reuptake of serotonin. As the reuptake of 5-hydroxy-tryptamine is blocked it leaves an increased level of 5-hydroxy-tryptamine in the synaptic cleft which then becomes available to bind to the postsynaptic receptor.
In the study below it indicates that the blockade of 5-HT2a receptors improves the clinical effects of SSRI drugs...
So are they prescribing 5-HT2a antagonists with SSRI compounds?
I don't know much about how these compounds are actually prescribed to individuals, however if they were prescribing SSRI compounds with 5-HT2a antagonists this would be an issue as well...
Abstract
The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects. They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic action requires weeks of treatment. This delay is the result of presynaptic and postsynaptic adaptive mechanisms secondary to reuptake inhibition. The prevention of a negative feedback mechanism operating at the 5-HT autoreceptor level enhances the neurochemical and clinical effects of SSRIs.
The blockade of 5-HT2A receptors also seems to improve the clinical effects of SSRIs. These receptors are located postsynaptically to 5-HT axons, mainly in the neocortex. Pyramidal neurons in the prefrontal cortex are particularly enriched in 5-HT2A receptors. Their blockade may affect the function of prefrontal–subcortical circuits, an effect that probably underlies the beneficial effects of the addition of atypical antipsychotic drugs, which are 5-HT2A receptor antagonists, to SSRIs in treatment-resistant patients.
The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects. They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic ...
www.ncbi.nlm.nih.gov
The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects. They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic ...
www.ncbi.nlm.nih.gov
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression
Pau Celada, M. Victoria Puig, Mercè Amargós-Bosch, Albert Adell, and Francesc Artigas
The above is a great research paper on the topic.
In general I would always be cautious when mixing psychedelics with any medication, specially those which are related to serotonin or mono amine oxidase.
-eg